Vitamin D2 Supplements May Lower Vitamin D3 Levels, Study Finds
A meta-analysis suggests that vitamin D2 supplements can reduce circulating vitamin D3, indicating the two forms are not interchangeable.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
ADHD Tied to Higher Risk of Late-Life Dementia in Large U.S. Study
A large retrospective analysis found that adults with ADHD had more than four times the risk of developing mild cognitive impairment or dementia, with genetic risk scores independently supporting the link.
FDA Clears Digital Therapeutic for Schizophrenia Negative Symptoms
The FDA cleared Motivista, a prescription digital therapeutic, as an adjunctive treatment for negative symptoms of schizophrenia.
Dutch court blocks Merck's subcutaneous Keytruda in Europe
A Dutch court sided with Halozyme in a patent dispute, barring sales of Merck's subcutaneous Keytruda in several European countries.
PhRMA sues over Medicare drug-price pilot as DOJ targets pharma fraud
New legal and enforcement actions signal a two-front federal push against pharmaceutical pricing and fraud.
Caribou Biosciences halts CAR-T work, lays off staff
The CRISPR biotech co-founded by Jennifer Doudna could not raise money for a Phase 3 trial of its off-the-shelf CAR-T therapy.
Democrats court MAHA voters with food agenda, skip vaccine injuries
Democratic candidates are adopting parts of the MAHA agenda on food and toxins while distancing themselves from RFK Jr.'s vaccine injury focus.
Life insurers penalize men on active surveillance for prostate cancer
An opinion piece argues that life insurers' classification of monitored prostate cancer as 'untreated' leads to coverage denials and higher premiums, despite medical guidelines recommending surveillance.
Duchenne drug shows promise but only for a small subset of patients
An experimental exon-skipping therapy for Duchenne muscular dystrophy appears to nearly stop the disease in some patients, yet its mutation-specific design leaves most families waiting.
ER visits by foreign-born patients fell sharply after ICE raids, study finds
A new JAMA Network Open study quantifies how heightened immigration enforcement drove immigrant patients away from emergency care in Los Angeles.
Cerevance Parkinson’s drug cuts 'off' time in Phase 3 trial
A Takeda-backed biotech says its experimental add-on therapy met the main goal in a late-stage Parkinson’s trial.
18 Nurses Run for Congress as Healthcare Tops Voter Concerns
At least 18 nurses are on the ballot for U.S. House and Senate seats, reflecting a push to address healthcare affordability and systemic strain.
How Cannabis May Trigger Anxiety: A Missing Brake in the Brain's Fear Center
New mouse research suggests cannabinoids intensify anxiety by removing a natural brake on specific neurons in the brain's fear center.
Disrupting bacterial chatter could treat gum disease gently
A new approach that interferes with chemical signals among oral bacteria may rebalance dental plaque without killing beneficial microbes.
Proposed $70,000 fee for student work program alarms biotech researchers
The Trump administration's plan to charge international students for Optional Practical Training could deter the foreign scientists who make up a large share of U.S. life science research.
Teladoc adds contactless vitals and AI scribe to virtual care platform
Teladoc is folding ambient AI documentation and camera-based vital monitoring into its Solo platform as it tries to ease clinician tool fatigue and reverse recent financial losses.
Report: Misaligned Incentives Drive US Healthcare Woes
A new Trilliant Health report ties rising costs, poor outcomes, and workforce shortages to systemic incentive misalignment.
Failed Execution Survivor Christa Pike Awake and Speaking, Lawyers Say
Six days after a botched lethal injection, Tennessee death row inmate Christa Pike is conscious and talking, though her long-term recovery remains uncertain.